0001209191-18-046097.txt : 20180809
0001209191-18-046097.hdr.sgml : 20180809
20180809190537
ACCESSION NUMBER: 0001209191-18-046097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180807
FILED AS OF DATE: 20180809
DATE AS OF CHANGE: 20180809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCloskey Shelley
CENTRAL INDEX KEY: 0001661906
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 181006746
MAIL ADDRESS:
STREET 1: C/O AQUINOX PHARMACUETICALS, INC.
STREET 2: 450 - 887 GREAT NORTHERN WAY
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
BUSINESS PHONE: 604-629-9223
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
STREET 2: SUITE 450
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-07
0
0001404644
AQUINOX PHARMACEUTICALS, INC
AQXP
0001661906
McCloskey Shelley
C/O AQUINOX PHARMACUETICALS, INC.
450 - 887 GREAT NORTHERN WAY
VANCOUVER
A1
V5T 4T5
BRITISH COLUMBIA, CANADA
0
1
0
0
VP, HR and Administration
Stock Option (Right to Buy)
3.07
2018-08-07
4
A
0
75000
0.00
A
2028-08-06
Common Stock
75000
75000
D
The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of August 7, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
/s/ Shelley McCloskey
2018-08-09